SEC Form 4 · accession 0001645627-18-000045
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 13, 2018
Accepted (ET)
Aug 16, 2018 · 11:27 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.0249 | A | 25,457,998 | D | |
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.0249 | A | 25,459,998 | D | |
| Common Stock | Aug 13, 2018 | P | 1,000 | $0.025 | A | 25,460,998 | D | |
| Common Stock | Aug 13, 2018 | P | 5,000 | $0.0243 | A | 25,465,998 | D | |
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.0243 | A | 25,467,998 | D | |
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.025 | A | 25,469,998 | D | |
| Common Stock | Aug 13, 2018 | P | 1,000 | $0.0261 | A | 25,470,998 | D | |
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.0261 | A | 25,472,998 | D | |
| Common Stock | Aug 13, 2018 | P | 3,000 | $0.0263 | A | 25,475,998 | D | |
| Common Stock | Aug 13, 2018 | P | 1,000 | $0.0261 | A | 25,476,998 | D | |
| Common Stock | Aug 13, 2018 | P | 5,000 | $0.0261 | A | 25,481,998 | D | |
| Common Stock | Aug 13, 2018 | P | 500 | $0.0261 | A | 25,482,498 | D | |
| Common Stock | Aug 13, 2018 | P | 5,000 | $0.0261 | A | 25,487,498 | D | |
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.0264 | A | 25,489,498 | D | |
| Common Stock | Aug 13, 2018 | P | 3,000 | $0.0269 | A | 25,492,498 | D | |
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.0269 | A | 25,494,498 | D | |
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.0269 | A | 25,496,498 | D | |
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.0269 | A | 25,498,498 | D | |
| Common Stock | Aug 13, 2018 | P | 500 | $0.0269 | A | 25,498,998 | D | |
| Common Stock | Aug 13, 2018 | P | 5,000 | $0.0269 | A | 25,503,998 | D | |
| Common Stock | Aug 13, 2018 | P | 2,000 | $0.0268 | A | 25,505,998 | D | |
| Common Stock | Aug 13, 2018 | P | 3,000 | $0.0266 | A | 25,508,998 | D |
Table II — derivative securities
No Table II lines on this filing.